Last Updated: June 25, 2026

Litigation Details for Actelion Pharmaceuticals US, Inc. v. Cipla Ltd. (D. Del. 2022)

✉ Email this page to a colleague

« Back to Dashboard

Actelion Pharmaceuticals US, Inc. v. Cipla Ltd. (D. Del. 2022)

Docket	⤷ Start Trial	Date Filed	2022-11-03
Court	District Court, D. Delaware	Date Terminated	2024-08-20
Cause	35:271 Patent Infringement	Assigned To	Gregory B. Williams
Jury Demand	None	Referred To
Patents	8,791,122; 9,284,280
Link to Docket	External link to docket

Small Molecule Drugs cited in Actelion Pharmaceuticals US, Inc. v. Cipla Ltd.

The small molecule drug covered by the patents cited in this case is ⤷ Start Trial .

Details for Actelion Pharmaceuticals US, Inc. v. Cipla Ltd. (D. Del. 2022)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Date Filed	Document No.	Description	Snippet	Link To Document
2022-11-03				External link to document
2022-11-03	4	Patent/Trademark Report to Commissioner of Patents	the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,791,122 ;9,284,280. (mpb) (… 3 November 2022 1:22-cv-01450 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2022-11-03	56	Notice of Service	Initial Invalidity Contentions for U.S. Patent Nos. 8,791,122 and 9,284,280 filed by Alembic Pharmaceuticals… 3 November 2022 1:22-cv-01450 835 Patent - Abbreviated New Drug Application(ANDA) None	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.